Skip to content

Abnormal Circulating Erythropoietin Concentration C5826395

Published: July 22, 2026Updated: August 20, 2026

Abnormal erythropoietin hormone levels affecting red blood cell production. It can cause anemia or excess red blood cells. Treatment depends on whether levels are too high or too low.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Pain or discomfort in the chest area that may indicate heart strain or reduced oxygen supply to heart muscles.

Seek immediate medical attention if chest pain is severe, radiating, or accompanied by shortness of breath, sweating, or nausea.

Fatigue and weakness

(constitutional)

Persistent tiredness and lack of energy due to reduced oxygen-carrying capacity from abnormal red blood cell production.

Frequency: 70-90% of patients

Shortness of breath

(respiratory)

Difficulty breathing or breathlessness, especially during physical activity, caused by inadequate oxygen delivery to tissues.

Frequency: 60-80% of patients

Dizziness

(neurologic)

Feeling lightheaded, unsteady, or faint, often worsening when standing up quickly.

Frequency: 50-70% of patients

Abnormal skin coloration

(dermatologic)

Unusually pale skin (with low EPO) or ruddy, reddish complexion (with high EPO) due to changes in red blood cell count.

Frequency: 40-60% of patients

Headache

(neurologic)

Persistent or recurrent headaches, often due to altered blood viscosity or oxygen deprivation to brain tissues.

Frequency: 30-50% of patients

Heart palpitations

(cardiovascular)

Awareness of rapid, forceful, or irregular heartbeat as the heart works harder to compensate for oxygen deficiency.

Frequency: 30-50% of patients

High blood pressure

(cardiovascular)

Elevated blood pressure, particularly associated with elevated erythropoietin levels causing increased blood viscosity.

Frequency: 40-60% of patients

Nausea or loss of appetite

(gastrointestinal)

Feeling sick to the stomach or reduced desire to eat, which may accompany the metabolic effects of abnormal EPO levels.

Frequency: 15-25% of patients

Difficulty concentrating

(neurologic)

Mental fog, trouble focusing, or reduced cognitive function due to chronic oxygen deprivation to brain tissues.

Frequency: 5-15% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Erythropoietin level monitoring

Regular blood testing to track erythropoietin concentrations and hemoglobin levels over time to identify patterns and underlying causes.

monitoring
3

Erythropoiesis-stimulating agents

Pharmacological agents that stimulate bone marrow red blood cell production when EPO deficiency is confirmed through diagnostic testing.

medication

Additional treatment options

Iron supplementation and nutrition optimization

Adequate iron intake supports erythropoiesis; dietary optimization with iron-rich foods and supplements when deficient.

lifestyle

Therapeutic phlebotomy

Blood removal procedure used when EPO levels are abnormally high causing polycythemia, reducing blood viscosity and cardiovascular risk.

procedure

Folate and B12 optimization

Ensuring adequate folate and vitamin B12 intake supports red blood cell maturation and normalizes hematopoiesis function.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Erythropoietin Concentration C5826395?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

KDIGO Clinical Practice Workgroup. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International Supplements. 2012;2(4):279-335.

guideline2012View source →
2

World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.

guideline2011View source →
3

Barbui T, Tefferi A, Vannucchi AM, et al. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised ELN recommendations. Leukemia. 2018;32(5):1057-1069.

guideline2018View source →
4

Jelkmann W. Erythropoietin: structure, control of production, and function. Physiological Reviews. 1992;72(2):449-489.

review1992View source →
5

Krantz SB. Erythropoietin. Blood. 1991;77(3):419-434.

review1991View source →
6

Bennett CL, Cournoyer D, Carson KR, et al. Erythropoiesis-stimulating agent use in cancer: pre-approval practices, documentation, and disclosure. Journal of Clinical Oncology. 2009;27(25):e8-e14.

meta_analysis2009View source →
7

Drüeke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. New England Journal of Medicine. 2006;355(20):2071-2084.

clinical_trial2006View source →
8

Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB. Postgraduate Haematology. 7th ed. Wiley-Blackwell; 2016.

textbook2016
9

American Society of Hematology. Clinical Practice Guidelines: Anemia. 2020.

position_statement2020View source →
10

Cairo MS, Bishop M. Reaching consensus on diagnosis and treatment of abnormal erythropoietin levels: international panel recommendations. British Journal of Haematology. 2005;131(5):600-609.

consensus2005View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Erythropoietin Concentration C5826395. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy